Degenerative disc disease involves the deterioration of intervertebral discs, which can lead to pain, reduced mobility, and other complications. Stem cell therapy aims to repair or regenerate the damaged disc tissue, enhancing its function and potentially alleviating symptoms.

1. Disc Regeneration: The intervertebral discs lack a robust blood supply and can’t regenerate effectively on their own. Stem cells have the potential to differentiate into disc cells and contribute to the repair and regeneration of the disc structure.
2. Pain Relief: Stem cells may help decrease inflammation in the spinal region and promote healing, thereby reducing pain associated with degenerative disc disease.
3. Improved Function: By restoring the integrity of the discs, stem cell therapy may improve overall spinal function and mobility.

Stem cell therapy for degenerative disc disease is still largely in the experimental phase, with ongoing clinical trials assessing its safety and effectiveness. The timeline for when this therapy might become widely accepted as a treatment option depends on the results of these studies.

1. Source of Stem Cells: Stem cells can be harvested from various sources, including bone marrow, adipose (fat) tissue, and even disc cells themselves (in the case of autologous stem cell therapy).
2. Delivery Method: The stem cells are typically injected directly into the affected disc or the surrounding area of the spine, which may enhance their effectiveness in targeting the degenerated tissue.
3. Mechanism of Action: Once injected, stem cells may contribute to tissue repair by differentiating into disc cells, releasing growth factors to stimulate healing, and reducing inflammation.